Skip to main content

Prosthesis User

0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Caesar FootN/A1 trial
EMG-Pattern Recognition ControllerN/A1 trial
Active Trials
NCT07075198Recruiting18Est. Aug 2026
NCT04272593Completed8Est. Jul 2022
Sound Pharmaceuticals
1 program
ESR Prosthetic Foot FirstN/A1 trial
Active Trials
NCT03505983Active Not Recruiting91Est. Sep 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesCaesar Foot
Human BioSciencesEMG-Pattern Recognition Controller
Sound PharmaceuticalsESR Prosthetic Foot First

Clinical Trials (3)

Total enrollment: 117 patients across 3 trials

Caesar Foot Take-Home Validation Testing

Start: Oct 2025Est. completion: Aug 202618 patients
N/ARecruiting
NCT04272593Human BioSciencesEMG-Pattern Recognition Controller

Pattern Recognition Prosthetic Control

Start: Nov 2020Est. completion: Jul 20228 patients
N/ACompleted
NCT03505983Sound PharmaceuticalsESR Prosthetic Foot First

Criteria for Advanced Prosthetic Foot Prescription

Start: Mar 2018Est. completion: Sep 202691 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 117 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.